Cadrenal Therapeutics, Inc.

Biotech Ponte Vedra, FL

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
Ponte Vedra, FL
Street
822 A1a North, Suite 306
Zip
32082

Offering

Total offering
$7.9M
Amount sold
$7.9M
First sale
Apr 1, 2026
Min investment
$0
Securities
—
Federal exemption
Rule 506(b)
Investors so far
1

How this filing compares

Ranked #14 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 2.6× the median.

Other Florida filings this week: Be Belong Group Corp., Collaborative Fund I - Charlotte Square Income, LP, MACE & SHIELD INVEST LP, MOSIR INVESTMENTS REIT LLC, NFluxion Inc

Leadership

Quang X. Pham — Executive Officer (also: Director)

Matthew Szot — Executive Officer

James Ferguson — Executive Officer

Jeffrey Cole — Executive Officer

John R. Murphy — Director

Steven Zelenkofske — Director

Glynn Wilson — Director

Lee Golden — Director

Filing details

Cadrenal Therapeutics, Inc. filed a Form D with the SEC on April 6, 2026.

Other newest Biotech companies

Other newest companies in Florida